<DOC>
	<DOCNO>NCT01134549</DOCNO>
	<brief_summary>The purpose study characterize safety tolerability KAI-4169 healthy young male .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics KAI-4169 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<criteria>Male 18 45 year age provide write informed consent Subject judge good health base medical history , physical examination , routine laboratory test History presence significant acute chronic illness ( e.g. , cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic disease ) accord investigator History ongoing medical condition require treatment prescription medication History asthma , severe allergy include skin reaction prior anaphylactic type reaction Clinically significant abnormality screen clinical examination laboratory safety test History drug alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Phase 1 Clinical Trials</keyword>
</DOC>